1,464
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

, , , , , , , , , , , , & show all
Article: e1149667 | Received 11 Nov 2015, Accepted 27 Jan 2016, Published online: 29 Jun 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.